Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
Go back to Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $4.76 | |||
| Open | $2.15 | 52 Week Low | $1.46 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $2.15 | EPS | $-1.91 | |||
| Volume | 75,655 | |||||
